NCT00002001View on ClinicalTrials.gov

The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

DRUG

Zalcitabine

DRUG

Didanosine

Trial Locations (5)

20007

Georgetown Univ Med Ctr / Main Hosp 4, Washington D.C.

37232

Vanderbilt School of Medicine, Nashville

80262

Univ of Colorado Health Sciences Ctr, Denver

Unknown

Saint Vincent's Hosp Med Centre, Darlinghurst

009275800

San Juan Veterans Administration Med Ctr, San Juan

Sponsors

Lead Sponsor

Glaxo Wellcome
All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002001 - The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease | Biotech Hunter | Biotech Hunter